Codis to Acquire Catalent's Nottingham Facility
Codis announced its intention to acquire Catalent's facility in Nottingham, UK. The move aims to expand Codis' spray drying capabilities across Europe.
Codis has entered into an agreement to acquire Catalent's manufacturing site located in Nottingham, United Kingdom. This strategic acquisition is expected to enhance Codis' capacity for end-to-end spray drying solutions within the European market.
The Nottingham facility brings expertise in oral solid dose development and small-scale commercial manufacturing, with over 20 years of operational history. Codis stated the acquisition will strengthen its particle engineering services, a key component in drug development and formulation.
This expansion follows recent investments by Codis in its own spray drying technologies. The integration of the Nottingham site is anticipated to create a comprehensive offering for clients seeking specialized drug delivery solutions.
Financial terms of the transaction were not disclosed. The acquisition is subject to customary closing conditions and regulatory approvals.